大剂量阿糖胞苷：药理学及临床方面 - Suppr

Suppr

超能文献

High-dose cytosine arabinoside: pharmacological and clinical aspects.

作者信息

Peters W G, Colly L P, Willemze R

机构信息

Department of Hematology, Leiden University, The Netherlands.

出版信息

Blut. 1988 Jan;56(1):1-11. doi: 10.1007/BF00321053.

DOI:10.1007/BF00321053

PMID:3276364

Abstract

摘要

相似文献

High-dose cytosine arabinoside: pharmacological and clinical aspects.大剂量阿糖胞苷：药理学及临床方面

Blut. 1988 Jan;56(1):1-11. doi: 10.1007/BF00321053.

High-dose cytosine arabinoside: advances in clinical pharmacology and therapeutic results.大剂量阿糖胞苷：临床药理学进展与治疗结果

Aust N Z J Med. 1983 Dec;13(6):561-3. doi: 10.1111/j.1445-5994.1983.tb02603.x.

Cytosine arabinoside in acute leukemia of childhood.

Cancer. 1971 Oct;28(4):815-8. doi: 10.1002/1097-0142(1971)28:4<815::aid-cncr2820280402>3.0.co;2-o.

[Treatment of acute leukemias in the infancy with cytosine arabinoside].[应用阿糖胞苷治疗婴儿急性白血病]

Minerva Pediatr. 1971 Jun 30;23(26):1125-9.

High-dose cytosine arabinoside in the initial treatment of acute leukemia.大剂量阿糖胞苷用于急性白血病的初始治疗。

Semin Oncol. 1985 Jun;12(2 Suppl 3):133-8.

Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.急性白血病中阿糖胞苷（ara-C）及大剂量阿糖胞苷的调控作用

Semin Oncol. 1985 Jun;12(2 Suppl 3):139-43.

Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital.在MD安德森医院开展的高剂量阿糖胞苷临床研究的进展

Semin Oncol. 1985 Jun;12(2 Suppl 3):98-104.

Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia.大剂量阿糖胞苷治疗难治性白血病的I-II期临床及药理学研究

Am J Med. 1986 Sep;81(3):387-94. doi: 10.1016/0002-9343(86)90287-1.

Treatment of refractory acute leukaemia with high dose cytosine arabinoside.高剂量阿糖胞苷治疗难治性急性白血病

Br J Haematol. 1982 Jul;51(3):497-8. doi: 10.1111/j.1365-2141.1982.tb02808.x.

Cytosine arabinoside and herpes zoster.阿糖胞苷与带状疱疹

Lancet. 1971 Jul 17;2(7716):166. doi: 10.1016/s0140-6736(71)92341-5.

引用本文的文献

Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms.海洋药物抗肿瘤：药物、先导化合物与作用机制

Mar Drugs. 2021 Aug 27;19(9):488. doi: 10.3390/md19090488.

New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase.用于实体瘤治疗的嘧啶抗代谢物新靶点。2：脱氧胞苷激酶。

Pharm World Sci. 1994 Apr 15;16(2):104-12. doi: 10.1007/BF01880661.

Acute myelogenous leukaemia in children.儿童急性髓系白血病

Eur J Pediatr. 1989 Feb;148(5):382-8. doi: 10.1007/BF00595892.

Cell kinetics after high dose cytosine arabinoside in patients with acute myelocytic leukemia.

Blut. 1990 Feb;60(2):76-80. doi: 10.1007/BF01720511.

Antineoplastic drugs in 1990. A review (Part II).1990年的抗肿瘤药物。综述（第二部分）。

Drugs. 1990 May;39(5):652-73. doi: 10.2165/00003495-199039050-00003.

The toxicity of cytarabine.阿糖胞苷的毒性。

Drug Saf. 1990 Jan-Feb;5(1):7-27. doi: 10.2165/00002018-199005010-00003.

Neutropenic enterocolitis following treatment with cytosine arabinoside-containing regimens for hematological malignancies: a potentiating role for amsacrine.

Ann Hematol. 1991 Apr;62(4):129-34. doi: 10.1007/BF01702926.

Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens.阿糖胞苷在急性髓系白血病治疗中的作用：大剂量方案的作用及地位

Ann Hematol. 1991 Apr;62(4):119-28. doi: 10.1007/BF01702925.

Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia.骨髓移植或化疗作为成人急性髓性白血病缓解后的治疗方法。

Ann Hematol. 1991 Feb-Mar;62(2-3):59-63. doi: 10.1007/BF01714901.

High-dose cytosine arabinoside intensification for acute nonlymphocytic leukemia in patients over 56 years of age.

Ann Hematol. 1992 Apr;64(4):185-9. doi: 10.1007/BF01696221.

本文引用的文献

Ara-C lung: noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia.阿糖胞苷肺：白血病患者接受阿糖胞苷治疗并发的非心源性肺水肿。

Am J Med. 1981 Feb;70(2):256-61. doi: 10.1016/0002-9343(81)90759-2.

Central nervous system toxicity of high-dose systemic cytosine arabinoside.大剂量全身应用阿糖胞苷的中枢神经系统毒性

Cancer. 1981 Dec 15;48(12):2577-82. doi: 10.1002/1097-0142(19811215)48:12<2577::aid-cncr2820481207>3.0.co;2-z.

Treatment of refractory acute leukaemia with high dose cytosine arabinoside.高剂量阿糖胞苷治疗难治性急性白血病

Br J Haematol. 1982 Jul;51(3):497-8. doi: 10.1111/j.1365-2141.1982.tb02808.x.

A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.大剂量1-β-D-阿拉伯呋喃糖基胞嘧啶治疗急性白血病和难治性淋巴瘤的初步研究：临床反应与药理学

Cancer Res. 1982 Apr;42(4):1587-94.

Acute pancreatitis in association with cytosine arabinoside therapy.与阿糖胞苷治疗相关的急性胰腺炎。

Cancer. 1982 Apr 1;49(7):1384-6. doi: 10.1002/1097-0142(19820401)49:7<1384::aid-cncr2820490714>3.0.co;2-6.

Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.人成髓细胞的致死率与阿糖呋喃胞苷掺入DNA相关。

Proc Natl Acad Sci U S A. 1981 May;78(5):3235-9. doi: 10.1073/pnas.78.5.3235.

The cytosine arabinoside (Ara-C) syndrome.阿糖胞苷综合征

Med Pediatr Oncol. 1981;9(3):257-64. doi: 10.1002/mpo.2950090309.

Corneal toxicity with systemic cytarabine.全身应用阿糖胞苷引起的角膜毒性。

Am J Ophthalmol. 1981 Apr;91(4):500-4. doi: 10.1016/0002-9394(81)90240-3.

Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine.局部用皮质类固醇治疗全身应用阿糖胞苷所致的角膜毒性。

Am J Ophthalmol. 1982 Nov;94(5):617-21. doi: 10.1016/0002-9394(82)90006-x.

The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of acute non-lymphocytic leukaemia in relapse.中等剂量阿糖胞苷（ID Ara-C）用于复发性急性非淋巴细胞白血病的治疗。

Br J Haematol. 1984 Jun;57(2):291-9. doi: 10.1111/j.1365-2141.1984.tb02898.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验